NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Neoplasms
Interventions: DRUG: epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab|DRUG: epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab
Sponsor: Lund University Hospital
Collaborators: Swedish Breast Cancer Group|Danish Breast Cancer Cooperative Group|Finnish Breast Cancer Group|Icelandic Breast Cancer Group